Clinical trial
Oxcarbazepine Versus Placebo in Childhood Autism
NCT00467753 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00467753 |
|---|---|
| Title | Oxcarbazepine Versus Placebo in Childhood Autism |
| Official title | Oxcarbazepine Versus Placebo in Childhood Autism |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug, Other |
| Interventions | Oxcarbazepine, Placebo/sugar pill |
| Enrollment | 5 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | May 1, 2007 |
| Last update posted | Jan 13, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: